218 related articles for article (PubMed ID: 25873265)
1. Leukocyte Cell-Derived Chemotaxin 2-Associated Amyloidosis: A Recently Recognized Disease with Distinct Clinicopathologic Characteristics.
Nasr SH; Dogan A; Larsen CP
Clin J Am Soc Nephrol; 2015 Nov; 10(11):2084-93. PubMed ID: 25873265
[TBL] [Abstract][Full Text] [Related]
2. Characterization and outcomes of renal leukocyte chemotactic factor 2-associated amyloidosis.
Said SM; Sethi S; Valeri AM; Chang A; Nast CC; Krahl L; Molloy P; Barry M; Fidler ME; Cornell LD; Leung N; Vrana JA; Theis JD; Dogan A; Nasr SH
Kidney Int; 2014 Aug; 86(2):370-7. PubMed ID: 24451324
[TBL] [Abstract][Full Text] [Related]
3. [Incidental finding of leukocyte cell-derived chemotaxin 2 - Associated amyloidosis in a liver].
Gibier JB; Gilbertson JA; Perbet R; Leriche W; Truant S; Leteurtre E; Gillmore JD; Gnemmi V
Ann Pathol; 2020 Nov; 40(6):472-477. PubMed ID: 32446730
[TBL] [Abstract][Full Text] [Related]
4. Leukocyte Cell-Derived Chemotaxin 2-Associated Renal Amyloidosis: A Case Report.
Kaur G; Bijin B; Saleem K; Sarsah B; Thajudeen B
Case Rep Nephrol Dial; 2017; 7(2):121-129. PubMed ID: 29464179
[TBL] [Abstract][Full Text] [Related]
5. Leukocyte Cell-Derived Chemotaxin-2 Amyloidosis (ALECT2) in a Patient With Lung Adenocarcinoma: An Autopsy Report and Literature Review.
Tariq H; Sharkey FE
Int J Surg Pathol; 2018 May; 26(3):271-275. PubMed ID: 29017384
[TBL] [Abstract][Full Text] [Related]
6. Leukocyte cell-derived chemotaxin 2 (LECT2)-associated amyloidosis is a frequent cause of hepatic amyloidosis in the United States.
Mereuta OM; Theis JD; Vrana JA; Law ME; Grogg KL; Dasari S; Chandan VS; Wu TT; Jimenez-Zepeda VH; Fonseca R; Dispenzieri A; Kurtin PJ; Dogan A
Blood; 2014 Mar; 123(10):1479-82. PubMed ID: 24415538
[TBL] [Abstract][Full Text] [Related]
7. ALECT2 amyloidosis: a new type of systemic amyloid highly prevalent in the Hispanic population.
Jiménez-Zepeda VH; Leung N
Rev Invest Clin; 2014; 66(3):269-73. PubMed ID: 25695244
[TBL] [Abstract][Full Text] [Related]
8. Rare, Yet Emerging Cause of Graft Dysfunction-ALECT 2 Amyloidosis.
Singh K; Sethi J; Duggal R; Joshi K; Bains AS
Indian J Nephrol; 2020; 30(3):204-206. PubMed ID: 33013073
[TBL] [Abstract][Full Text] [Related]
9. Mixed leukocyte cell-derived chemotaxin 2 and amyloid A renal amyloidosis in a Kazakh-German patient.
Gödecke VA; Röcken C; Steinmüller-Magin L; Nadrowitz F; Fleig SV; Haller H; Wagner AD
Clin Kidney J; 2017 Apr; 10(2):266-268. PubMed ID: 28584627
[TBL] [Abstract][Full Text] [Related]
10. [Renal disorders associated with monoclonal gammopathies: diagnostic and therapeutic progress].
Bridoux F; Delbes S; Sirac C; Pourreau F; Puyade M; Desport E; Jaccard A; Fermand JP; Touchard G
Presse Med; 2012 Mar; 41(3 Pt 1):276-89. PubMed ID: 22244725
[TBL] [Abstract][Full Text] [Related]
11. Renal leukocyte chemotactic factor 2 (ALECT2)-associated amyloidosis in Chinese patients.
Li DY; Liu D; Wang SX; Yu XJ; Cui Z; Zhou FD; Zhao MH
Amyloid; 2020 Jun; 27(2):134-141. PubMed ID: 32024381
[No Abstract] [Full Text] [Related]
12. Leukocyte chemotactic factor 2 amyloidosis (ALECT2) is a common form of renal amyloidosis among Egyptians.
Larsen CP; Ismail W; Kurtin PJ; Vrana JA; Dasari S; Nasr SH
Mod Pathol; 2016 Apr; 29(4):416-20. PubMed ID: 26867784
[TBL] [Abstract][Full Text] [Related]
13. Renal leukocyte chemotactic factor 2 (LECT2) amyloidosis in First Nations people in Northern British Columbia, Canada: a report of 4 cases.
Hutton HL; DeMarco ML; Magil AB; Taylor P
Am J Kidney Dis; 2014 Nov; 64(5):790-2. PubMed ID: 25064673
[TBL] [Abstract][Full Text] [Related]
14. Renal amyloidogenic leukocyte chemotactic factor 2 combined with IgA nephropathy: A case report.
Xu H; Jia Y; Wang X; Wang H; Yu J; Hao W
Medicine (Baltimore); 2022 Jul; 101(29):e29638. PubMed ID: 35866785
[TBL] [Abstract][Full Text] [Related]
15. Clinically occult amyloidosis derived from leukocyte chemotactic factor 2 (ALECT 2) with cardiac involvement complicating renal transplantation: case report and literature review.
Eletta O; Ali M; Grieff A; Puri S; Matsuda K; Bongu A; Fyfe B
Cardiovasc Pathol; 2021; 55():107375. PubMed ID: 34371188
[TBL] [Abstract][Full Text] [Related]
16. Karyomegalic interstitial nephritis with a novel FAN1 gene mutation and concurrent ALECT2 amyloidosis.
Law S; Gillmore J; Gilbertson JA; Bass P; Salama AD
BMC Nephrol; 2020 Feb; 21(1):74. PubMed ID: 32111193
[TBL] [Abstract][Full Text] [Related]
17. Clinical, morphologic, and genetic features of renal leukocyte chemotactic factor 2 amyloidosis.
Larsen CP; Kossmann RJ; Beggs ML; Solomon A; Walker PD
Kidney Int; 2014 Aug; 86(2):378-82. PubMed ID: 24522497
[TBL] [Abstract][Full Text] [Related]
18. LECT-2 amyloidosis: what do we know?
Mann BK; Bhandohal JS; Cobos E; Chitturi C; Eppanapally S
J Investig Med; 2022 Feb; 70(2):348-353. PubMed ID: 34848562
[TBL] [Abstract][Full Text] [Related]
19. De novo leukocyte chemotactic factor 2 amyloidosis in a pediatric renal allograft, 15 years post-transplant.
Shamir ER; Lee MM; Walavalkar V
Pediatr Transplant; 2019 May; 23(3):e13371. PubMed ID: 30714275
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis, pathogenesis and outcome in leucocyte chemotactic factor 2 (ALECT2) amyloidosis.
Rezk T; Gilbertson JA; Rowczenio D; Bass P; Lachmann HJ; Wechalekar AD; Fontana M; Mahmood S; Sachchithanantham S; Whelan CJ; Wong J; Rendell N; Taylor GW; Hawkins PN; Gillmore JD
Nephrol Dial Transplant; 2018 Feb; 33(2):241-247. PubMed ID: 29401357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
